September 2020—DiaSorin Molecular announced that its Simplexa Flu A/B & RSV Direct Gen II kit has received the CE mark. The kit delivers continued comprehensive strain coverage and accurate detection in a sample-to-answer format that does not require extraction.
Designed for use with the Liaison MDX instrument, the assay can be run alone or with the Simplexa COVID-19 Direct kit. The assays are designed to be performed at the same time, allowing for differential diagnosis of COVID-19, influenza, and RSV.
DiaSorin Molecular has submitted the assay for 510(k) clearance.
DiaSorin Molecular, 562-240-6500